Identification of mesenchymal stromal cell survival responses to antimicrobial silver ion concentrations released from orthopaedic implants by Souter, Paul et al.
This is a repository copy of Identification of mesenchymal stromal cell survival responses 
to antimicrobial silver ion concentrations released from orthopaedic implants.




Souter, Paul, Vaughan, John, Butcher, Kerry et al. (7 more authors) (Accepted: 2020) 
Identification of mesenchymal stromal cell survival responses to antimicrobial silver ion 
concentrations released from orthopaedic implants. Scientific Reports. 18950. ISSN 2045-




This article is distributed under the terms of the Creative Commons Attribution (CC BY) licence. This licence 
allows you to distribute, remix, tweak, and build upon the work, even commercially, as long as you credit the 
authors for the original work. More information and the full terms of the licence here: 
https://creativecommons.org/licenses/ 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
1
Vol.:(0123456789)
Scientific Reports |        (2020) 10:18950  | https://doi.org/10.1038/s41598-020-76087-1
www.nature.com/scientificreports
Identification of mesenchymal 
stromal cell survival responses 
to antimicrobial silver ion 
concentrations released 
from orthopaedic implants
Paul Souter1, John Vaughan1, Kerry Butcher1, Adam Dowle2, Jim Cunningham1, 
James Dodd1, Michael Hall1, Darren Wilson1, Alan Horner1 & Paul Genever2*
Antimicrobial silver  (Ag+) coatings on orthopaedic implants may reduce infection rates, but should 
not be to the detriment of regenerative cell populations, primarily mesenchymal stem/stromal cells 
(MSCs). We determined intramedullary silver release profiles in vivo, which were used to test relevant 
 Ag+ concentrations on MSC function in vitro. We measured a rapid elution of  Ag+ from intramedullary 
pins in a rat femoral implantation model, delivering a maximum potential concentration of 7.8 µM, 
which was below toxic levels determined for MSCs in vitro  (EC50, 33 µM). Additionally, we present 
in vitro data of the reduced colonisation of implants by Staphylococcus aureus. MSCs exposed to 
 Ag+ prior to/during osteogenic differentiation were not statistically affected. Notably, at clonal 
density, the colony-forming capacity of MSCs was significantly reduced in the presence of 10 µM 
 Ag+, suggesting that a subpopulation of clonal MSCs was sensitive to  Ag+ exposure. At a molecular 
level, surviving colony-forming MSCs treated with  Ag+ demonstrated a significant upregulation 
of components of the peroxiredoxin/thioredoxin pathway and processes involved in glutathione 
metabolism compared to untreated controls. Inhibition of glutathione synthesis using l-buthionine 
sulfoxamine eliminated MSC clonogenicity in the presence of  Ag+, which was rescued by exogenous 
glutathione.
Surgical site infection following orthopaedic trauma imparts a significant clinical and economic burden on 
patients and healthcare systems. It is estimated to double the median healthcare costs and patient hospitalisa-
tion time at centres within the United  States1. In a European study specifically investigating infection of tibial 
fractures, treatment costs were estimated to increase by 6.5-times compared to patients with no  complications2.
Persistent infections are primarily caused by the presence of bacterial biofilms attached to the surfaces of 
implanted materials, with colonisation of fracture fixation devices caused by Staphylococcus aureus in approxi-
mately 30% of  cases3. These micro-colonies are highly organised, sessile communities surrounded by extracellular 
polymeric substances that are able to evade both the host’s defence mechanisms and  antibiotics4–9. In vivo, the 
formation of a biofilm is greatly enhanced by the implantation of an inert material, and was the cause of failure 
observed in many  patients10,11. It is therefore evident that the prevention of bacterial adhesion and subsequent 
biofilm formation can prevent implant-associated infection. With this in mind, gentamicin-coated intramed-
ullary (IM) nails for use in fracture repair have been commercialised to block implant associated infection by 
Gram-negative  bacteria12.
However, with the rise in antibiotic resistance, the use of a broad spectrum antimicrobial may be more appro-
priate. As a result, there has been growing interest in the use of silver for orthopaedic applications. In addition to 
the direct action on many microbial strains, the use of silver has also been shown to potentiate the effectiveness 
and broaden the bacterial species activity of  antibiotics13–15. The wide bactericidal effects of silver are caused 
by disruption of the cell membrane, damage to DNA and prevention of replication, denaturation of proteins 
and enzymes that contribute to the loss of cell integrity as well as the disruption of energy metabolism, in part 
caused by the generation of reactive oxygen species (ROS)16–20. Currently, the application of silver to orthopaedic 
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megaprostheses implanted during bone resection as a result of osteosarcoma has proven to reduce the incidence 
of infection in these compromised  patients21–23. The application of silver to orthopaedic trauma devices such as 
intramedullary nails, could therefore have a similar clinical impact.
Fracture repair requires the action of immune cells, chondrocytes and osteoblasts, the numbers and regula-
tion of which are influenced by mesenchymal stem/stromal cells (MSCs) that act as a source or progenitors, 
giving rise to reparative osteochondral  tissue24. MSCs are supplied to the fracture site from the surrounding soft 
tissue, periosteum and bone marrow, all or which may be disrupted in a severe fracture, therefore preservation 
of existing MSC populations and their function is of  importance25. Specifically, the impact of silver ions  (Ag+) 
on repair of the fracture site and the subsequent generation of ROS that also occurs in eukaryotic cells, needs 
to be considered, particularly since the level of ROS can affect the lineage divergence of MSCs, with decreased 
osteogenesis occurring under in vitro conditions of oxidative  stress26–28.
Here, we determined the  Ag+ release profile from intramedullary implants to identify how exposure to rele-
vant in vivo concentrations of silver ions affected MSC function and survival responses in vitro. Our findings pro-
vide insight into the potential clinical use of this metal for biofilm prevention in orthopaedic trauma situations.
Results
Synthesis and characterisation of intramedullary pin implants. Silver ions were integrated on to 
implant surfaces and inductively coupled plasma mass spectrometry (ICP-MS) quantification of total  Ag+ con-
firmed nominal target loading of approximately 50 µg/cm2 (pins: mean, 50.36 µg/cm2 SEM ± 0.76, n = 6).
Staphylococcus aureus adhesion to silver coated Ti64 grit blasted pins. Control pin implants, 
without  Ag+ coatings, supported bacterial colonisation over the test period, with a mean surface count of 5.00 
 log10 CFU/sample after 1 day rising to 7.11  log10 CFU/sample at day 33 (Fig. 1a). Colonisation was significantly 
reduced on  Ag+ coated pins (> 4  log10 CFU/sample) over control counts at 24 h, maintaining this distinction 
at day 7 and 14 re-challenges (> 4  log10 CFU/sample). At these time points all replicates displayed counts at or 
below the detection limit. At day 21,  Ag+ coated samples displayed a degree of colonisation, however values 
remained below control counts by > 4  log10 CFU/sample. Colonisation was detected in  Ag+ coated pins at day 
33 that was comparable to control samples at earlier time points (day 1, 7 and 14), but still reduced compared to 
control (Fig. 1a).
Rapid elution of  Ag+ from implants within intramedullary canal environment. To determine 
 Ag+ elution kinetics,  Ag+ coated titanium pins  (Ag+, 50.36 µg/cm2 SEM ± 0.76) were implanted in to rat femo-
ral intramedullary canals (Fig. 1b,c) and the  Ag+ determined in the recovered implant (Fig. 1d), the femurs 
receiving the implants (Fig. 1e) and plasma (Fig. 1f). Results revealed a burst release within the 24 h following 
implantation, equating to approximately 70% (mean 25.15 μg, SEM ± 1.45 μg) of the pre-implantation content, 
with little significant release over the remaining study period (Fig.  1d). A corresponding rapid elevation in 
plasma and femoral  Ag+ content was detected at Day 1 that remained elevated at Day 3 (Fig. 1e,f). Maximum 
Figure 1.  (a–f) Surface recovery of S. aureus from silver-coated grit blasted Ti64 pins following in vitro 
challenge (a), line represents the limit of detection of 0.95 CFU/mL, (b) confirmation of pin implantation during 
in vivo assessment of silver elution, (c) microCT scan of rat femur highlighting intramedullary canal volume. 
Measurement of total Ag from (d) recovered implants (µg), (e) operated femurs (µg), and silver concentration in 
(f) plasma (μg/mL), red line represents limit of detection (= 0.00125 μg/mL). All values are means ± SEM (n = 3) 
determined via ICP-MS for samples taken at termination (Day 1, 2, 3 and 28). Statistical analysis by one-way 
ANOVA using Tukey correction for multiple comparisons, significance indicated against Day 0 by *p < 0.05, **p 
< 0.01, ****p < 0.0001, Day 1 by #p < 0.05, Day 2 by $p < 0.05 and Day 3 by ~p < 0.05.
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plasma concentration (0.019 μg/mL, SEM ± 0.004 μg/mL) declined following the Day 1 peak and was reduced to 
baseline over the remaining study period. Femoral  Ag+ content at Day 3 (7.00 μg; SEM ± 0.58 μg) significantly 
decreased by Day 28 (2 μg) (Fig. 1f).
The free canal volume (i.e. available canal volume with implant in situ) determined from microCT recon-
structions (Fig. 1c) equated to 43 µL, therefore the theoretical maximum  Ag+ concentration within the canal 
following initial release equated to 6.00 μM (mean 5.42 μM, SEM ± 0.31, Supplementary Table S1). In the event 
of instant total release of  Ag+ from an implant,  Ag+ within the canal was calculated to reach a peak of 7.97 μM 
(mean 7.72 μM, SEM ± 0.12). For the purpose of in vitro testing, an  Ag+ value of 10 μM was taken forwards as a 
maximum test concentration. Further data detailing Day 1 implant elution, total plasma  Ag+ and unaccounted 
 Ag+ are available in Supplementary Table S1.
In vitro susceptibility of MSCs to  Ag+ is increased at clonal density. The effect of  Ag+ dose on 
primary MSC and human osteoblast (hObs) cultures provided calculated  EC50 values of 33.06 μM and 41.4 μM, 
respectively (Fig. 2a,b). MSC proliferation in the presence of  Ag+ was unaffected over 3 days at concentrations 
below the  EC50 as determined by EdU incorporation (Fig. 2c). Colony-forming capacity of MSCs as measured 
by colony number and percentage area was also unaffected by exposure to sub-EC50  Ag+ concentrations during 
the initial 3 days of culture (which broadly replicated the exposure period determined during the in vivo elution 
Figure 2.  (a–g) Effect of  Ag+ dose response on percentage viability of (a) hObs  (EC50: 41.4 μM) and (b) 
MSCs  (EC50: 33.06 μM). (c) proliferation (EdU) and CFU-f number (d) and area (e) of MSCs at sub-EC50 
concentrations (≤ 10 µM) during 3 day exposure. CFU-f number (f) and area (g) during continuous  Ag+ 
exposure. All values are means ± SEM (n = 3). Images in the right panel are representative of 6-well plates, 
stained with crystal violet (blue) and analysed (brown) for CFU-f number and area;  Ag+ concentrations for 
the plates are (L–R): top row, 0, 0.1, 0.5 μM; bottom row, 1, 5, 10 μM. Statistical analysis was performed for all 
 Ag+ groups compared to control (by one-way ANOVA using Dunnett’s correction for multiple comparisons), 
significance indicated by *p < 0.05, **p < 0.01, ****p < 0.0001.
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study) (Fig. 2d,e). However, when MSCs were treated with  Ag+ for the duration of the assay period, 10 µM  Ag+ 
caused a significant reduction in colony number and area (Fig. 2f,g).
MSC colony formation is unaffected by previous exposure to  Ag+. Maintenance of MSC clonal 
expansion capacity following  Ag+ exposure is necessary for the continued functioning of bone marrow stroma 
during and subsequent to fracture repair. This property was determined through the secondary seeding of  Ag+ 
exposed CFU-f using a two-stage assay design (Fig. 3a). Essentially, CFU-f were exposed to  Ag+ at 0, 1 and 10 µM 
Figure 3.  (a–e) Two-stage assay design (a) used to determine the continued MSC colony-forming capacity 
and  Ag+ tolerance. Clonal density MSCs were cultured for 14 days ± Ag+ after which colonies of treatment 
groups were pooled and reseeded at clonal density and re-cultured ± Ag+ for a further 14 days. The resulting 
clonogenic capacity was measured, represented by (b) CFU-f number and (c) CFU-f diameter.  Ag+ exposure 
during initial culture is represented on the x-axis with different  Ag+ exposures during Stage 2 displayed. Values 
represent mean (± SEM, n = 3). Statistical analysis by ANOVA; both using appropriate correction for multiple 
comparisons. Analysis performed for data within each ‘Stage 1’  Ag+ concentration, comparing against control, 
represented by ***p < 0.001, ****p < 0.0001; and against 1 μM  Ag+ represented by $$p < 0.005. Comparison of each 
‘Stage 2’  Ag+ treatment to its equivalent from the ‘Stage 1’ control group (#p < 0.05). Effect on CFU-f number 
when  Ag+ is applied in MSC-CM. (d) Effect of 10 µM  Ag+ treatment on CFU-f number (± SEM, n = 3) in the 
presence of non-conditioned and MSC-conditioned medium using primary MSCs (p = 0.52) and Y201 MSCs 
(p = 0.81) in the CFU-f assays. Statistical analysis by two-way ANOVA using Sidak’s correction for multiple 
comparisons, significance indicated by *p < 0.05, **p < 0.001. (e) Representative images of crystal violet stained 
CFU-f for primary MSCs and Y201 MSCs.
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concentrations for 14 days (Stage 1). After this time, the surviving CFU-fs from each treatment were trypsinised, 
re-plated at CFU-f density in fresh plates and re-exposed to  Ag+ at 0, 1 and 10 µM concentrations for a further 
14 days (Stage 2). This protocol enabled us to test the hypothesis that colonies surviving an initial  Ag+ exposure 
represented an  Ag+ resistant MSC subpopulation. Stage 2 CFU-f number for untreated controls was unaffected 
by previous exposure to  Ag+. However, the surviving Stage 1  Ag+ exposed MSCs remained susceptible to fur-
ther  Ag+ exposure in Stage 2 with significant decreases in CFU-f number, irrespective of initial  Ag+ treatment 
(Fig. 3b) indicating that  Ag+ exposure did not select for a resistant MSC subtype.
An inverse correlation was observed between CFU-f diameter and  Ag+ concentration (Fig. 3c). This rela-
tionship was apparent irrespective of pre-exposure to  Ag+, however the reduction was only significant for those 
colonies derived from MSCs previously cultured with silver.
Conditioned medium from MSCs maintains clonogenicity during exposure to  Ag+. We have 
found that colony-forming MSCs grown at single cell densities are much more sensitive to  Ag+ exposure than 
confluent or near confluent MSC cultures. We hypothesised that this may be due to the decreased availability of 
secreted, protective signalling factors in CFU-f cultures compared to more densely packed MSC monolayers. To 
test this hypothesis, conditioned medium (CM) was collected from confluent MSC cultures and applied to the 
CFU-f assays in the presence and absence of silver ions. We found that the CFU-f number reduction observed at 
10 µM  Ag+ could be rescued by the addition of CM (Fig. 3d). Both human primary MSCs and the Y201 human 
MSC line (used here as a reproducible model human MSC clonal  line29) showed recovery of CFU-f number near 
to that of control when treated with  Ag+ in CM. There was also a notable increase in colony size of the CM groups 
compared to unconditioned medium controls (Fig. 3e).
Glutathione synthesis is upregulated in MSCs of surviving CFU-f in response to  Ag+. We have 
shown that a proportion of MSCs persist as CFU-fs following exposure to  Ag+ ions, suggesting that  Ag+ may 
activate survival mechanisms in MSCs, depending on cell density. To identify these mechanisms, Y201 MSCs 
were used in a proteomic screen of  Ag+ exposed CFU-f compared to untreated control CFU-f. Liquid chro-
matography tandem mass spectrometry (LC–MS/MS) proteomic analysis identified 5050 quantifiable proteins, 
with peak area-based label-free relative quantification applied using Progenesis QI software (Fig. 4a). Of those 
identified, 89 were significantly upregulated in  Ag+ exposed CFU-f compared to controls, while 21 were sig-
nificantly downregulated (FDR < 0.05) (Fig.  4b). Supplementary figures  S1(a–d) demonstrate the differentia-
tion of sample groups and consistency of biological replication in the proteomic data set. Gene Ontology (GO) 
analysis identified several differentially regulated functional responses including several metabolic pathways, as 
well as cellular detoxification (GO:1990748), response to stress (GO:0006950) and response to xenobiotic stimu-
lus (GO:0009410) (Fig. 4c). Comparison of proteomic data to known KEGG pathways highlighted glutathione 
metabolism as the major upregulated cellular response to  Ag+ exposure. Further KEGG pathway analysis drew 
attention to the upregulation of proteins involved with DNA replication and nucleotide excision repair (PCNA, 
LIG1, CUL4A).
Validation of the proteomic evidence was provided by quantitative Polymerase Chain Reaction (qPCR) analy-
sis of the oxidative stress response of three primary MSC donors (Fig. 4d). Data were normalised to B2M, which 
identified 39 genes showing mean fold-change > 1.5 (Fig. 4e). Genes of glutathione synthesis/metabolism (GPX3, 
GPX5, GPX6, GR, GCLM), peroxiredoxin (PRDX1) and thioredoxin (TXN, TXNRD1) showed activation of 
these pathways upon  Ag+ exposure. Additionally, increases in the stress inducible regulator of NRF2, seques-
tome 1 (SQSTM1), heme oxygenase-1 (HMOX1), NAD(P)H:quinone oxidoreductase-1 (NQO1) and SOD1 
were also noted for all donors. GO functional analysis related to biological processes was performed on the 
qPCR data, with an FDR (false discovery rate) below 5% the threshold for significance (Supplementary Fig. S2). 
Highlights of those terms include: the removal of superoxide radicals (GO:0019430), response to hydrogen 
peroxide (GO:0042542), regulation of reactive oxygen species metabolic process (GO:2000377) and glutathione 
metabolic process (GO:0006749). Furthermore, cellular response to cadmium (GO:0071276) and cellular copper 
homeostasis (GO:0006878) all indicate at the mechanisms employed to ensure management of metal ions that 
could result in toxicity. Of those identified, glutathione metabolic process (GO:0006749) was replicated from 
the proteomic analysis (Supplementary Fig. S3), the only functional process to be so.
Using primary MSCs, we identified increased GCLM immunostaining, a component of glutathione synthesis, 
and thioredoxin in  Ag+ exposed CFU-f compared to untreated controls (Fig. 4f). Analysis of whole colony area 
did not reveal any variation in the expression of either protein.
We used a pharmacological inhibitor of glutathione synthesis, l-buthionine sulfoxamine (BSO), to determine 
the functional effects of glutathione on CFU-f survival while under  Ag+ exposure conditions. As observed before, 
a significant reduction in CFU-f number was noted at 10 µM  Ag+ in the absence of glutathione inhibition. How-
ever with the addition of 1 µM BSO, a significant reduction in CFU-f was observed with  Ag+  ≥ 5 µM, compared 
to their equivalent  Ag+ only control (Fig. 4g). In the case of 10 µM  Ag+, CFU-f formation was eliminated in the 
presence of BSO. Recovery of CFU-f number was achieved through the concomitant treatment of 10 µM  Ag+/
BSO with exogenous glutathione (GSH-MEE).
Effects of silver on adipogenic differentiation is dependent on exposure time. The level of lipid 
deposition by MSCs as measured by Oil Red O staining revealed a reduction in adipogenesis when exposed 
to silver compared to controls. While a short term exposure during the initial 3 days of differentiation had no 
effect, continuous silver treatment during differentiation resulted in significant declines compared to untreated 
control and short term sliver exposure (p < 0.001) (Supplementary Fig. S4a). In contrast, pre-treatment of MSCs 
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with silver during expansion, with subsequent silver-free differentiation, caused a slight but significant increase 
in adipogenesis compared to control (p < 0.05, Supplementary Fig. S4b).
Osteogenic differentiation of MSCs is unaffected by  Ag+ exposure. The effect of  Ag+ exposure on 
MSC osteogenic differentiation capacity was assessed by measurement of alkaline phosphatase (ALP) activity. 
Osteogenic differentiation of MSCs was performed in the presence and absence of 10 µM  Ag+, with ALP activity 
normalised to DNA determined for short-term (3 day) exposure and continual  Ag+ exposure groups (Fig. 5a). 
Cultures treated during the initial 3-day period exhibited a 16% decline from control, while a 26% reduction 
was observed for cultures treated for the entire differentiation period, however both findings did not reach 
significance (p = 0.582 and p = 0.246, respectively) (Fig. 5a and a,i). Furthermore, analysis of DNA data provided 
additional evidence of the long-term viability of confluent cultures at continual sub-EC50  Ag+ concentrations 
(Fig. 5a, ii).
We had previously found that  Ag+ exposure could inhibit MSC CFU-f capacity. We therefore determined if the 
osteogenic differentiation of MSCs was affected following CFU-f culture in the presence of  Ag+. We found that 
osteogenic capacity (as measured by normalised and total ALP activity) was unaffected by previous exposure to 
 Ag+ during CFU-f (Fig. 5b and b,i). However, and in contrast to previous observations, DNA counts (relating to 
cell number) were significantly elevated in cultures from MSCs previously exposed to  Ag+ (Fig. 5b,ii).
CFU-Ob capacity is inhibited during  Ag+ exposure. MSCs were plated at colony-forming seeding 
density and then exposed to osteogenic conditions to determine the effect of  Ag+ exposure on the formation of 
CFU-Ob. In a manner similar to the effects of  Ag+ exposure on CFU-f growth, the generation of ALP-positive 
CFU-Ob was decreased in the presence of continuous  Ag+. Colony number in the 10 µM  Ag+ treatment group 
declined by 62% from control but did not reach statistical significance (p = 0.112, Fig. 5c), however total CFU-Ob 
area was significantly reduced at this sub-EC50 concentration (Fig. 5d).
Discussion
The consequences of infection of orthopaedic trauma devices are both severe for the patient and costly to the 
healthcare  system2,30. Although the risk of infection for open tibial fractures is as high as 36%, the primary aim 
of treating all at risk injuries with implants comprising an anti-microbial technology should not jeopardise suc-
cessful  union31. Here, we have investigated the use of silver as a broad spectrum antimicrobial in the prevention 
of biofilm formation, specifically its elution within an intramedullary setting. We then used the in vivo elution 
profile data to determine in vitro effects on MSC colony-forming capacity and differentiation, the mechanisms 
of MSC tolerance to  Ag+ induced oxidative stress, and the outcomes of fracture healing.
The elution profile of any additive from an implant is of importance for not only efficacy but also determining 
the safety of such products during pre-clinical evaluations. With regards to testing silver-coated implants, valu-
able data can be gained from laboratory-based testing, for example using saline or simulated body fluid as carrier 
solutions. However due to the chemical complexities of using this transition metal, the analysis of silver elution 
from implants placed in clinically relevant in vivo localities is  essential32,33. Previous reporting of release profiles 
from silver technologies have shown a rapid increase in silver at day 2 following sub-cutaneous implantation, 
declining thereafter from day  615. Consistent with those data, we also found a rapid elevation in silver concen-
tration at the implantation site, additionally correlating this to the concomitant rise in plasma concentrations 
and a large decline of implant-associated  Ag+. Importantly, this was mapped during the initial period following 
implantation and allowed calculation of the maximal  Ag+ burst release within the free canal space, which was 
applied in our in vitro investigation. While the elution of some pharmaceuticals has been assessed in this way, 
to our knowledge, the determination of silver elution from such an implant location has not previously been 
 described34. Importantly, the same implants proved capable of reducing in vitro colonisation by S. aureus over 
a 14 day period, a pathogen commonly the cause of implant related  infection3.
Figure 4.  (a–g) Proteomic and molecular identification of the oxidative stress response of MSCs during 
exposure to  Ag+. (a) Protein relative abundance heat map from Y201 CFU-f under control and  Ag+ exposure 
conditions (green < 15, red > 20). (b) Volcano plot of 5050 quantified proteins, negative/positive  log2 data equate 
to  Ag+ group down/upregulated, respectively. 15.19% of proteins were significantly differentially regulated 
accepting Progenesis QI calculated q-value of < 0.05 (orange), reducing to 2.17% (green) when applying 
additional multiple test correction to 5% FDR (Benjamini and Hochberg). (c) GO terminology of biological 
processes (FDR < 0.05) associated with differentially upregulated proteins of  Ag+ cultured Y201 CFU-f. (d) Fold 
change of oxidative stress response genes in 3 primary MSC donors (grey, pink/red and green; dots represent 
different genes), the red line represents 1.5 fold-change. (e) Oxidative stress genes exhibiting ≥ 1.5 fold-change 
following  Ag+ exposure versus controls, values are mean ± SEM (n = 3). (f) Immunostaining of CFU-f for 
GCLM and TRX (both red), counterstained with DAPI (blue). Scale bar: 50 µm. (g)  Ag+ induced reduction 
of CFU-f is potentiated by inhibition of glutathione synthesis with BSO, with recovery aided by exogenous 
GSH. Results represent the mean CFU-f number ± SEM (n = 3). Statistical analysis by one-way ANOVA using 
Sidak’s correction for multiple comparisons. Comparisons performed against control represented by *p < 0.05, 
**p < 0.01, ***p < 0.001, ****p < 0.0001. Additional comparisons made against treatment groups containing the 
same level of  Ag+ (e.g. 1 μM  Ag+ v 1 μM  Ag+/1 μM BSO), significance indicated compared to 5 μM  Ag+ ($) and 
10 μM  Ag+ (#). Exogenous GSH in the presence/absence of 10 µM Ag + and 1 µM BSO. Comparisons performed 
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MSCs account for < 0.01% of the cells isolated from the bone marrow, therefore the capacity to proliferate from 
a low density population provides the niche with a rapid source of progenitors required for skeletal remodelling 
and  repair35. The maintenance of a viable population of colony-forming stromal cells is of paramount importance, 
and the CFU-f assay can be used as an in vitro assessment of this  ability36,37. Through this assay we revealed a 
reduction of MSC colony-forming capacity in the presence of sub-toxic  Ag+ that prompted the analysis of the 
mechanisms of tolerance employed by the surviving colonies. ROS production following heavy metal ion expo-
sure is regulated by superoxide dismutase (SOD) and catalase (CAT) in addition to several other antioxidant 
enzymes and their components, such as the predominant source of cellular thiol groups,  glutathione38. However, 
variations in oxidative stress protein synthesis between tissues have been identified during in vivo cadmium 
 exposure39. In vitro molecular and protein profiling of these cellular mechanisms has ordinarily been performed 
after short term exposure using confluent cultures, while investigating specific proteins involved in oxidative 
Figure 5.  (a–d) Normalised ALP activity of MSCs following  Ag+ exposure (a) during, and (b) prior to 
differentiation. (a) Normalised ALP activity in the presence of 10 μM  Ag+ for either the initial 3 days of culture 
 (Ag+ 10 μM (Day 0–3)) or for the entire differentiation period  (Ag+ 10 μM). Control cultures received  Ag+ free 
osteogenic differentiation medium only. Total ALP activity (i) and DNA quantification (ii) were measured from 
cell lysates. (b) Normalised ALP activity of CFU-f derived MSCs cultured in the presence/absence of 10 μM 
 Ag+ prior to osteogenic differentiation in  Ag+ free medium. Total ALP activity (i) and DNA quantification (ii) 
were measured from cell lysates. The results represent the mean ± SEM for three donors, performed in triplicate. 
CFU-Ob, (c) number, and (d), total percentage area during  Ag+ exposure. All values are means ± SEM (n = 3). 
Representative image (right) of CFU-Ob, with  Ag+ concentrations for plates (L–R): top row, 0, 0.1, 0.5 μM; 
bottom row, 1, 5, 10 μM. Statistical analysis performed by ANOVA using appropriate correction for multiple 
comparisons. Significance against control indicated by *p < 0.05, **p < 0.01.
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stress  management40–42. Significantly, for orthopaedic applications, the data presented here provides an insight 
into the global mechanisms employed by chronically exposed  Ag+ tolerant clonogenic MSCs.
The glutathione synthesis inhibitor, BSO, elevates intracellular ROS and sensitises systems to sub-toxic 
doses of oxidative agents; recovery of cell viability can be achieved through the administration of exogenous 
 glutathione43,44. For the first time with MSCs, we used this technique to confirm the findings of the proteomic, 
bioinformatics and qPCR analysis and in doing so revealed the importance of glutathione to the clonogenic 
survival of MSCs following exposure to  Ag+ ions. Our data also highlighted a reduction in colony number dur-
ing prolonged BSO treatment, although reduction in in vitro cell viability was not observed by other research-
ers investigating the effects over shorter time periods, with a greater BSO  concentration45,46. Additionally, the 
inhibition of the glutathione system potentiated the effect of sub-toxic  Ag+ concentrations, which overwhelmed 
the remaining defence mechanisms of the normally sliver-tolerant sub-population.
Oxidative DNA damage resulting from ROS can be induced in cells exposed to  Ag+47. While the risk of 
transversion mutations is abrogated by several DNA repair mechanisms, the upregulation of proteins involved 
in global genome nucleotide excision repair were identified in our assessment of MSC clonogenicity following 
silver treatment. This suggests that neutralisation of ROS alone is not sufficient to enable colony formation in 
sliver-treated MSCs and that other pathways are employed in order to maintain the MSC population.
Increased oxidative stress impairs fracture healing in  rodents48,49. In a study by Lippross et al. a decline in the 
quality of bone remodelling was described and has been supported by evidence of reduced osteogenic differen-
tiation of MSCs in vitro while under conditions of oxidative stress, including those caused by  Ag+  exposure49–52. 
Osteoblast activity plays an important role in the formation of the hard callus during secondary fracture healing, 
an event that occurs several weeks following the initial injury. We determined that the retention time of silver 
within the bone was minimal in our model, additionally, we found that adipogenesis was differentially altered 
dependent on the timing of exposure. While a limitation of our study is our measurement of one indicator of 
osteogenesis (ALP), with further work investigating other markers, for example by qPCR, required to provide 
more robust information, we report that little effect on the osteogenic capacity of confluent MSCs and cell viabil-
ity was observed even while under the 10 µM  Ag+ conditions, a concentration that is in line with the maximum 
silver elution characteristics measured using the rat in vivo model. Of interest, however, was the significant 
decline in MSC clonogenicity that was discovered while under these same conditions. The importance of MSC 
number at a fracture site was highlighted by Hernigou et al. and it is conceivable that our observation of reduced 
clonogenicity during conditions of oxidative stress may explain the reports of reduced healing in fracture models 
with localised induced  ROS48,49,53. Further investigation of MSC function following in vivo exposure to the silver 
coated implants would have provided valuable additional insight.
Together, our data indicate that clinically relevant silver concentrations remain sub-toxic to MSCs at high 
density, but can result in a decreased colony-forming capacity. Tolerant CFU-fs show upregulated mechanisms 
to neutralise ROS and minimise the impact of DNA damage, with the implication that those cells maintain their 
osteogenic capacity, allowing the progression of fracture healing. These findings indicate that silver may have a 
role to play in reducing the incidence of fracture fixation related infection, bringing potential benefits to both 
patients and healthcare system.
Materials and methods
The following methods describe the investigation of  Ag+ release from intramedullary implants, translating this 
to in vitro methods that assessed the effect on MSC function.
Preparation and characterisation of silver coated implants. Titanium alloy (Ti-6Al-4V) rods 
(20 mm length × 1.1 mm diameter) were passivated in 10 M sodium hydroxide at a temperature of 60 °C (pins, 
1 h 50 min) followed by incubation in 0.1 M silver nitrate (Alfa Aesar) at 60 °C for 1 h, to achieve a targeted silver 
dose of ~ 50 µg/cm2. All implants were gamma sterilised prior to surgery (25–40 kGy).
Total silver analysis was determined pre- and post-implantation (where appropriate). Individual implants were 
placed in 1:2 (v/v) nitric acid/dH2O and incubated overnight at room temperature (RT). Solutions were vortexed 
and diluted 1:1000 (v/v) in 1% nitric acid. Silver content was determined against an  Ag+ standard (0.2–20 ppb) 
using the Agilent 8800 ICP-MS Triple Quad (Stockport, UK) in the presence of a 500 ppb rhodamine internal 
standard.
Extended time-point repeat challenge microbiology testing of silver coated pins. Silver coated 
pins in cryovial tubes (NUNC, UK) were inoculated with 1 mL Staphylococcus aureus ATCC 25923 (1 × 104 CFU/
mL) in 10% Foetal Bovine Serum (FBS)/PBS and incubated horizontally (37 °C with agitation at 150 rpm). Each 
time point (24 h, 7, 14, 21 and 33 days, n = 5/time point) received a 50% media change at 3–4 day intervals, 
replacing 500 μL of test suspension with and equivalent volume of fresh 10% FBS in PBS (Note: the 24 h time 
point received no media change and 33 day sample received no media change between days 18 and 27).
For each time point, samples allotted for analysis were transferred to a fresh cryovial and 1 mL of fresh 
inoculum added to each. Following a further 24 h incubation, the pins were placed in to clean tubes, washed 
6 × with sterile PBS before transfer to neutraliser (0.85% NaCl, 0.4% sodium thioglycollate, 1% Tween 20) and 
the colonising bacteria from the surface were recovered as described in ASTM E2871-13. Briefly this comprised 
vortex mixing for 30 s, followed by sonication for 30 s (45 kHz), this was repeated, with a final vortex before 
serial dilution in MRD and plating on to Petrifilm (3M, UK). All Petrifilm were incubated for at least 48 h at 
32 °C before counting. Twenty-four hour samples underwent the same recovery process, without the additional 
24 h re-challenge following initial incubation.
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In vitro cell culture. Mesenchymal stem/stromal cells (MSCs) of human origin were isolated from bone 
marrow aspirate (Lonza) or excised bone donated by patients undergoing primary arthroplasty surgery (NHS, 
Clifton Park Hospital, UK). Informed consent was obtained from all subjects. Collections and all methods were 
carried out in accordance with relevant guidelines and regulations under approval from the University of York 
Biology Ethical Committee Review Board and NHS Local Research Ethics Committee. Clonal MSCs, termed 
Y201, were generated from primary bone marrow derived MSCs engineered to overexpress human telomerase 
reverse transcriptase (hTERT)29. The use of Y201 MSCs as a model system has been indicated where appro-
priate. Both primary MSCs and Y201 MSCs were expanded in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% FBS, 100 Units/mL Penicillin and 100 μg/mL Streptomycin (37 °C, 5%  CO2). Human 
osteoblasts (hObs) were purchased from PromoCell (Germany) and cultured in osteoblast growth media (Pro-
moCell). Cells were passaged using 0.25% Trypsin–EDTA once 90% confluent. All reagents purchased from 
Sigma (Poole, UK) unless otherwise stated.
In vitro viability and proliferation. Primary MSCs seeded at 3.125 × 104 cells/cm2 in 96-well plates were 
incubated for 24 h before addition of an  Ag+ dose response (range 8.75–100 μM,  Ag2SO4, Alfa Aesar, Heysham, 
UK). After a further 24 h, WST-1 reagent was added and the optical density read at 440 nm and 600 nm after 1 h. 
Results were converted to viability as a percentage of the untreated control. Proliferation over 72 h was assessed 
using 5-ethynyl-2′-deoxyuridine (EdU) incorporation (ThermoFisher, Loughborough, UK). MSCs were seeded 
for 24 h in to 24-well plates (2.5 × 103 cells/cm2) before addition of  Ag+ (0–10 µM). After 72 h, cultures were 
counterstained with Hoechst and image analysis performed using ImageJ, providing the percentage of EdU 
positive cells.
CFU-f and CFU-Ob formation. Primary MSC cultures at clonal density (10 cells/cm2) were established 
in DMEM + 20% HyClone FBS (GE Healthcare, Little Chalfont, UK) to generate CFU-f (colony-forming unit 
fibroblast). As for the assessment of viability and proliferation, medium was changed 24 h after seeding for that 
containing  Ag+ (0–10 µM). Medium was changed twice per week, with one subset of plates receiving  Ag+ for the 
first 3 days only, after which medium was without silver. Colony formation (defined as ≥ 50 cells) was assessed 
after 14 days following crystal violet staining (0.05% w/v crystal violet) for 20 min.
CFU-Ob (colony-forming unit osteoblast) were generated as described for CFU-f, but supplementing the 
medium with osteogenic additives at the medium change 24 h after seeding (50 μg/mL l-ascorbic acid,  10–8 M 
dexamethasone, 3 mM β-glycerophosphate). Alkaline phosphatase (ALP) positive colonies were identified after 
14 days using 1% Fast Red TR/0.2% Naphthol AS-MX applied for 2 min.
Differentiation of MSCs. Primary MSCs were culture expanded, seeded in to well-plates for 24 h prior to 
the addition of osteogenic differentiation medium (described above) ± 10 µM  Ag+. As before, one group received 
 Ag+ free medium after 3 days while maintaining 10 µM  Ag+ in the second treatment group. Adipogenic differen-
tiation media  (10-6 M Dexamethasone, 500 µM 3-Isobutyl-1-methylxanthine, 1 µg/mL Insulin from bovine pan-
creas, 100 µM Indomethacin) and osteogenic media, were changed twice per week with time points of 21 days 
(adipogenic) and seven and 14 days (osteogenic). Controls underwent the same medium changes (with/without 
 Ag+) and time points.
Adipogenic cultures were rinsed (1xPBS) and fixed for ten minutes in 10% formaldehyde (Polysciences, USA) 
followed by a rinse with  dH2O and the addition of Oil Red O working solution for five minutes. The stain was 
removed and the wells washed with 60% Isopropanol before a final rinse with tap water. Lipid bound Oil Red O 
was quantified through removal with 99% Isopropanol and the optical density measured at 520 nm (Multiskan 
GO, Thermo Fisher, UK,). For osteogenic analysis, at the specified time points, cultures were lysed and ALP activ-
ity analysed against a p-nitrophenol standard (pNP, 0–250 nmol/mL) using a pNPP substrate (5 mM). Optical 
density (405 nm) was measured after 1 h (37 °C). Data were normalised to DNA, quantified using PicoGreen 
(ThermoFisher), measured at Ex: 485 nm/Em: 538 nm. Differentiation following MSC expansion as CFU-f 
was determined, with MSCs seeded at clonal density ± 10 μM  Ag+ for 14 days, before differentiation in  Ag+ free 
medium. Time points and analysis were as previously described.
CFU-f formation following  Ag+ exposure. The continued clonogenic capacity of MSCs following  Ag+ 
treatment and the existence of an  Ag+ tolerant subpopulation that maintained colony formation under further 
 Ag+ exposure were assessed using a two-stage CFU-f assay (see Fig.  3a for schematic description). In brief, 
primary MSCs seeded at clonal density were cultured in medium (0, 1 or 10 µM  Ag+) and assigned as ‘Stage 1’. 
Medium was changed twice per week for 14 days, after which, cells from the same treatment group (e.g. control) 
were pooled. MSCs were re-seeded in to further 6-well plates at clonal density (‘Stage 2’) and medium (± Ag+) 
changed as before. After 14  days, the colonies of the ‘Stage 2’ plates were counted and diameters measured. 
Assessment of CFU-f diameter was performed using the Zeiss Zen 2.3 Lite software.
CFU-f formation in conditioned medium. The effect of environmental signals on MSC (primary and 
Y201 MSCs) clonogenicity was determined by culturing clonally seeded MSCs in conditioned medium (MSC-
CM). Tissue culture flasks of MSCs at 70% confluence were rinsed with phosphate buffered saline (PBS) and 
further culture in serum free DMEM for 24 h. Medium was removed, centrifuged and filtered (0.45 µm) and 
HyClone FBS added to give 20% (stored 2–8 °C). ‘Non-conditioned’ (i.e. basal) or ‘Conditioned’ medium were 
used during media changes (± 10 µM  Ag+) with colonies assessed as before after 14 days.
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qPCR of oxidative stress pathway. RNA was extracted from primary MSC-generated CFU-f (± 10 µM 
 Ag+). CFU-f were pelleted and RNA isolated according to RNeasy Mini Kit protocol (Qiagen, Manchester, UK). 
cDNA synthesis was performed with 500 ng mRNA per sample reaction using  RT2 First Strand Kit (Qiagen). 
QPCR was performed using the  RT2 Human Oxidative Stress PCR Array (Qiagen, Cat: PAHS-065Z) with SYBR 
Green detection run on the Thermo Fisher Quantstudio 3 Real-Time PCR System (95 °C for 10 min followed 
by 40 cycles of 95 °C for 15 s, 60 °C for one minute, a final melt curve of 95 °C for 15 s, 60 °C for one minute, 
95 °C for one second). Fold-changes were calculated for each donor, normalising to β-2-microglobulin (B2M).
Global proteomic analysis of CFU-f. Ag+ cultured Y201 CFU-f were washed and lysed in urea lysis 
buffer added at 5:1 (v:v) of the cell pellet before undergoing three bursts of microtip sonication at 15 watts, 
cooling on ice for one minute between bursts. Reduction, alkylation, trypsin digestion and peptide fractionation 
was performed as described by Geoghegan et al. for Aedes aegypti  midguts54. Peptide fractions were loaded onto 
an UltiMate 3000 RSLCnano HPLC system (Thermo) equipped with a PepMap 100 Å  C18, 5 µm trap column 
(300 µm × 5 mm Thermo) and a PepMap, 2 µm, 100 Å,  C18 EasyNano nanocapillary column (75 μm × 500 mm, 
Thermo). Flow rate was 300 nL/min and the column temperature 40 °C. Separation used gradient elution of 
aqueous 1% (v:v) formic acid (solvent A) and aqueous 80% (v:v) acetonitrile containing 1% (v:v) formic acid 
(solvent B). The linear multi-step gradient profile was: 3–10% B over 7 min, 10–35% B over 30 min, 35–99% B 
over 5 min and then proceeded to wash with 99% solvent B for 4 min. The nanoLC system was interfaced with an 
Orbitrap Fusion hybrid mass spectrometer and positive ESI–MS and  MS2 spectra were acquired using Xcalibur 
software (version 4.0, Thermo).  MS1 spectra were acquired in the Orbitrap with Easy-IC: 120,000 resolution, 
scan range: m/z 375–1500. Data-dependent acquisition was performed in top speed mode using a 1 s cycle and 
50 s dynamic exclusion.  MS2 spectra were acquired in the linear ion trap with HCD activation energy of 32%. 
Peak area derived relative quantification was obtained from non-conflicting precursor intensities using Pro-
gensis QI as detailed  previously55. Relative abundances were normalised between high pH  C18 fractions using 
total ion intensity. Database searching was performed against the human subset of the UniProt database (Date 
20180123; 20,244 sequences; 11,338,534 residues) using Mascot (Matrix Science Ltd., version 2.5.1), filtering 
identifications through the Percolator algorithm to achieve a global 1% FDR. Accepted quantifiable proteins 
were further filtered to require a minimum of two unique peptides. Multiple test corrected q-values for differen-
tial abundance were calculated in Progenesis QI with the Hochberg and Benjamini FDR estimation additionally 
applied for further stringency.
Immunocytochemistry of CFU-f (GCLM and TRX). Detection of γ-glutamylcysteine synthetase 
(GCLM) and thioredoxin (TRX) was in CFU-f of primary MSCs cultured with  Ag+ on glass coverslips (using a 
HeLa cell positive control). Slides were fixed with ice cold 100% methanol (10 min) rinsed with PBS and incu-
bated with 5% goat serum/PBS at room temperature (1 h). Primary antibody incubation (1 h, RT) also occurred 
in 5% goat serum/PBS 10  μg/mL polyclonal rabbit anti-GCLM IgG (Cat: NBP1-33405, RRID: AB_2107841, 
Novusbio, UK) and 4  μg/mL polyclonal rabbit anti-thioredoxin IgG (Cat: NBP2-48873, RRID AB_2819005, 
Novusbio). Slides were rinsed before incubation with 10 μg/mL Alex fluor 647-conjugated goat anti-rabbit IgG 
(H + L) cross adsorbed (1 h, RT; Cat: A-21244, RRID: AB_2535812, ThermoFisher) and counterstained with 
2 μg/mL DAPI. Coverslips were mounted in aqueous mounting media (Abcam, Cambridge, UK). All immuno-
fluorescence imaging was performed using the Zeiss Axio Imager.M2 LSM 710 confocal microscope (Carl Zeiss, 
Cambridge, UK).
Inhibition of glutathione synthesis and addition of GSH-MEE. CFU-f from primary MSCs were cul-
tured with  Ag+ (0, 1, 5 and 10 μM) in the presence/absence of a pharmacological inhibitor of γ-glutamylcysteine 
synthetase, l-buthionine-sulfoxamine (BSO, 0.01, 0.1 1 μM). Recovery the glutathione pathway in BSO treated 
cultures was through media supplementation with 2 mM GSH-MEE. Media were changed twice per week with 
CFU-f number assessed at 14 days.
In vivo  Ag+ release from intramedullary implants. Study design was approved by the Smith and 
Nephew Animal Welfare and Ethical Review Board in compliance with the Animals (Scientific Procedures) 
Act 1986, taking into consideration the requirements for reduction, replacement and refinement. Twelve male 
Sprague Dawley rats (250–300 g) were randomised in to four groups consisting of three animals per group. 
Each group was allocated to a time point of 24, 48, 72 h or 28 days. Animals were group housed in temperature 
controlled rooms at 21 ± 2 °C with a relative humidity of 55 ± 10% and artificial lighting cycle of 12 h light/dark. 
Sub-cutaneous antibiotic prophylaxis (Septrin, 24 mg/kg), was provided prior to surgery and twice per day for 
the initial 2 days of the study. In addition, intra-peritoneal injections of Buprenorphine analgesia (0.05 mg/kg) 
and medetomidine sedative (0.1 mg/kg) were provided. Following surgery, buprenorphine (0.05 mg/kg) was 
administered every eight hours for a minimum of 48 h. Animals were anaesthetised using an Isoflurane/Oxygen/
Nitrous oxide mixture. Access to the femoral canal was via an entry hole in the inter-condylar notch of the left 
hind leg. The test article was inserted and the wound closed using absorbable sub-articular sutures. Following 
surgery, the animals underwent X-rays and were returned to individual housing to recover, after which they were 
returned to the group. Animals were sacrificed at allocated time points and plasma samples prepared from whole 
blood collected in heparin sodium salt anticoagulant. The femurs were removed and the implants retrieved.
Silver quantification of plasma and femurs. Plasma samples were diluted 1:25 (v/v) in 1% nitric acid 
and the  Ag+ content determined against a matrix matched standard [0.05–2 ppb, 4% rat plasma (Innovative 
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Research)]. Femurs were heated to 700 °C for four hours and mixed with a 1:2 (v/v) nitric acid/dH2O solu-
tion and left overnight at RT. Samples were diluted 1:200 (v/v) in 1% nitric acid and  Ag+ quantified as before 
(0.2–20 ppb).
Statistical analysis. Data were expressed as the mean ± SEM. In vitro experiments were performed with a 
minimum of three primary donors. Data were interrogated as stated in the individual methods using appropri-
ate multiple comparison test. Statistical analysis was performed using GraphPad Prism 7 software (GraphPad 
Software, La Jolla, CA, USA).
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